Ivermectine Cf (Ivermectin)

Ivermectin binds to glutamate‑gated chloride channels in the nerve and muscle cells of invertebrates, increasing chloride influx, which hyperpolarizes the cells, causing paralysis and death of the parasite while sparing human cells.

The dosage of Ivermectine Cf is determined by the prescribing clinician based on the specific indication, patient weight, age and clinical condition. The prescriber selects the appropriate strength, frequency and duration according to approved guidelines and local regulatory recommendations.

Safety data for ivermectin in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional after evaluating the clinical situation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ivermectin is distinct from benzimidazoles or praziquantel in that it targets glutamate‑gated chloride channels, offering a broad spectrum against nematodes and ectoparasites. Compared with alternatives, it often requires a single oral dose, has a favorable safety profile, but may be less effective against certain filarial species that need combination therapy.

Ivermectine Cf should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture, light and humidity. Keep the product out of reach of children and avoid storing in areas with extreme temperature fluctuations.

The medication is taken orally, usually with water, on an empty stomach or as directed by the prescriber. Tablets should be swallowed whole and not chewed or crushed unless specifically instructed. Administration timing may vary depending on the infection being treated.

Although rare, serious adverse events can include severe skin reactions such as Stevens‑Johnson syndrome, hepatotoxicity, neurologic effects like seizures or altered consciousness, and anaphylactic reactions. Patients should seek immediate medical attention if they experience any of these symptoms.

Ivermectine Cf is contraindicated in individuals with known hypersensitivity to ivermectin or any excipients, and it should be avoided in patients with high Loa loa microfilarial loads due to the risk of severe neurologic complications. Use is also discouraged in pregnant or breastfeeding women unless clearly indicated by a healthcare professional.